HKSE - Delayed Quote HKD

MedSci Healthcare Holdings Limited (2415.HK)

Compare
0.960
+0.130
+(15.66%)
At close: February 14 at 4:08:39 PM GMT+8
Loading Chart for 2415.HK
DELL
  • Previous Close 0.830
  • Open 0.860
  • Bid 0.900 x --
  • Ask 0.970 x --
  • Day's Range 0.860 - 0.970
  • 52 Week Range 0.610 - 3.800
  • Volume 832,500
  • Avg. Volume 130,923
  • Market Cap (intraday) 514.407M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 10.67
  • EPS (TTM) 0.090
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Medsci Healthcare Holdings Limited operates as an online professional physician platform service provider in the People's Republic of China and the United States. The company offers precision omni-channel marketing solutions, including precision detailing, medical content creation, and online survey services; physician platform solutions, such as medical knowledge and clinical study assistance services; and real-world study solutions comprising digital real-world evidence-based research. It primarily serves pharmaceutical and medical device companies, physicians, non-profit organizations, and hospitals. The company was founded in 2012 and is headquartered in Shanghai, the People's Republic of China.

medscihealthcare.com

534

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 2415.HK

View More

Performance Overview: 2415.HK

Trailing total returns as of 2/14/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

2415.HK
9.09%
HANG SENG INDEX
12.76%

1-Year Return

2415.HK
65.47%
HANG SENG INDEX
42.45%

3-Year Return

2415.HK
89.15%
HANG SENG INDEX
7.88%

5-Year Return

2415.HK
89.15%
HANG SENG INDEX
18.68%

Compare To: 2415.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 2415.HK

View More

Valuation Measures

Annual
As of 2/14/2025
  • Market Cap

    514.41M

  • Enterprise Value

    -708.48M

  • Trailing P/E

    10.96

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.58

  • Price/Book (mrq)

    0.42

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.06%

  • Return on Assets (ttm)

    0.54%

  • Return on Equity (ttm)

    3.82%

  • Revenue (ttm)

    308.46M

  • Net Income Avi to Common (ttm)

    43.37M

  • Diluted EPS (ttm)

    0.090

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.15B

  • Total Debt/Equity (mrq)

    0.40%

  • Levered Free Cash Flow (ttm)

    21.28M

Research Analysis: 2415.HK

View More

Company Insights: 2415.HK

Research Reports: 2415.HK

View More

People Also Watch